nodes	percent_of_prediction	percent_of_DWPC	metapath
Vardenafil—CYP3A5—Temsirolimus—kidney cancer	0.117	0.22	CbGbCtD
Vardenafil—CYP3A4—Everolimus—kidney cancer	0.0675	0.127	CbGbCtD
Vardenafil—CYP3A4—Temsirolimus—kidney cancer	0.0456	0.0859	CbGbCtD
Vardenafil—CYP3A5—Erlotinib—kidney cancer	0.0438	0.0826	CbGbCtD
Vardenafil—CYP3A5—Paclitaxel—kidney cancer	0.0401	0.0756	CbGbCtD
Vardenafil—CYP3A5—Sorafenib—kidney cancer	0.0356	0.0672	CbGbCtD
Vardenafil—CYP3A5—Vincristine—kidney cancer	0.0346	0.0652	CbGbCtD
Vardenafil—CYP3A5—Sunitinib—kidney cancer	0.0289	0.0544	CbGbCtD
Vardenafil—CYP3A4—Pazopanib—kidney cancer	0.0239	0.0451	CbGbCtD
Vardenafil—CYP3A4—Erlotinib—kidney cancer	0.0171	0.0322	CbGbCtD
Vardenafil—CYP3A4—Paclitaxel—kidney cancer	0.0156	0.0295	CbGbCtD
Vardenafil—CYP3A4—Sorafenib—kidney cancer	0.0139	0.0262	CbGbCtD
Vardenafil—CYP3A4—Vinblastine—kidney cancer	0.0137	0.0259	CbGbCtD
Vardenafil—CYP3A4—Vincristine—kidney cancer	0.0135	0.0254	CbGbCtD
Vardenafil—CYP3A4—Sunitinib—kidney cancer	0.0113	0.0212	CbGbCtD
Vardenafil—CYP3A4—Doxorubicin—kidney cancer	0.00843	0.0159	CbGbCtD
Vardenafil—Sildenafil—CYP1A1—kidney cancer	0.0015	1	CrCbGaD
Vardenafil—Urethral disorder—Capecitabine—kidney cancer	0.000207	0.000643	CcSEcCtD
Vardenafil—Paraesthesia—Vincristine—kidney cancer	0.000206	0.000642	CcSEcCtD
Vardenafil—Rash—Everolimus—kidney cancer	0.000205	0.000638	CcSEcCtD
Vardenafil—Dermatitis—Everolimus—kidney cancer	0.000205	0.000638	CcSEcCtD
Vardenafil—Headache—Vinblastine—kidney cancer	0.000205	0.000637	CcSEcCtD
Vardenafil—Angioedema—Paclitaxel—kidney cancer	0.000204	0.000636	CcSEcCtD
Vardenafil—Headache—Everolimus—kidney cancer	0.000204	0.000634	CcSEcCtD
Vardenafil—Hypotension—Gemcitabine—kidney cancer	0.000204	0.000634	CcSEcCtD
Vardenafil—Abdominal pain—Dactinomycin—kidney cancer	0.000203	0.000633	CcSEcCtD
Vardenafil—Visual impairment—Capecitabine—kidney cancer	0.000203	0.000632	CcSEcCtD
Vardenafil—Asthenia—Sorafenib—kidney cancer	0.000203	0.00063	CcSEcCtD
Vardenafil—Malaise—Paclitaxel—kidney cancer	0.000202	0.000628	CcSEcCtD
Vardenafil—Vertigo—Paclitaxel—kidney cancer	0.000201	0.000625	CcSEcCtD
Vardenafil—Syncope—Paclitaxel—kidney cancer	0.000201	0.000624	CcSEcCtD
Vardenafil—Hypersensitivity—Sunitinib—kidney cancer	0.0002	0.000623	CcSEcCtD
Vardenafil—Pruritus—Sorafenib—kidney cancer	0.0002	0.000622	CcSEcCtD
Vardenafil—Vomiting—Erlotinib—kidney cancer	0.0002	0.000621	CcSEcCtD
Vardenafil—Musculoskeletal discomfort—Gemcitabine—kidney cancer	0.000199	0.000618	CcSEcCtD
Vardenafil—Gastrointestinal disorder—Vincristine—kidney cancer	0.000199	0.000617	CcSEcCtD
Vardenafil—Rash—Erlotinib—kidney cancer	0.000198	0.000616	CcSEcCtD
Vardenafil—Dermatitis—Erlotinib—kidney cancer	0.000198	0.000615	CcSEcCtD
Vardenafil—Palpitations—Paclitaxel—kidney cancer	0.000198	0.000615	CcSEcCtD
Vardenafil—Insomnia—Gemcitabine—kidney cancer	0.000197	0.000614	CcSEcCtD
Vardenafil—Eye disorder—Capecitabine—kidney cancer	0.000197	0.000613	CcSEcCtD
Vardenafil—Headache—Erlotinib—kidney cancer	0.000197	0.000612	CcSEcCtD
Vardenafil—Tinnitus—Capecitabine—kidney cancer	0.000197	0.000612	CcSEcCtD
Vardenafil—Loss of consciousness—Paclitaxel—kidney cancer	0.000197	0.000612	CcSEcCtD
Vardenafil—Pain—Vincristine—kidney cancer	0.000197	0.000612	CcSEcCtD
Vardenafil—Paraesthesia—Gemcitabine—kidney cancer	0.000196	0.000609	CcSEcCtD
Vardenafil—Flushing—Capecitabine—kidney cancer	0.000196	0.000609	CcSEcCtD
Vardenafil—Cardiac disorder—Capecitabine—kidney cancer	0.000196	0.000609	CcSEcCtD
Vardenafil—Asthenia—Sunitinib—kidney cancer	0.000195	0.000607	CcSEcCtD
Vardenafil—Dyspnoea—Gemcitabine—kidney cancer	0.000194	0.000605	CcSEcCtD
Vardenafil—Nausea—Vinblastine—kidney cancer	0.000194	0.000604	CcSEcCtD
Vardenafil—Somnolence—Gemcitabine—kidney cancer	0.000194	0.000603	CcSEcCtD
Vardenafil—Convulsion—Paclitaxel—kidney cancer	0.000194	0.000603	CcSEcCtD
Vardenafil—Nausea—Everolimus—kidney cancer	0.000193	0.000601	CcSEcCtD
Vardenafil—Diarrhoea—Sorafenib—kidney cancer	0.000193	0.000601	CcSEcCtD
Vardenafil—Pruritus—Sunitinib—kidney cancer	0.000192	0.000598	CcSEcCtD
Vardenafil—Angiopathy—Capecitabine—kidney cancer	0.000191	0.000595	CcSEcCtD
Vardenafil—Immune system disorder—Capecitabine—kidney cancer	0.000191	0.000593	CcSEcCtD
Vardenafil—Arthralgia—Paclitaxel—kidney cancer	0.000191	0.000592	CcSEcCtD
Vardenafil—Myalgia—Paclitaxel—kidney cancer	0.000191	0.000592	CcSEcCtD
Vardenafil—Chest pain—Paclitaxel—kidney cancer	0.000191	0.000592	CcSEcCtD
Vardenafil—Mediastinal disorder—Capecitabine—kidney cancer	0.00019	0.000591	CcSEcCtD
Vardenafil—Anxiety—Paclitaxel—kidney cancer	0.00019	0.00059	CcSEcCtD
Vardenafil—Face oedema—Doxorubicin—kidney cancer	0.00019	0.00059	CcSEcCtD
Vardenafil—Hypersensitivity—Dactinomycin—kidney cancer	0.00019	0.00059	CcSEcCtD
Vardenafil—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—kidney cancer	0.000189	0.000588	CcSEcCtD
Vardenafil—Gastrointestinal disorder—Gemcitabine—kidney cancer	0.000188	0.000586	CcSEcCtD
Vardenafil—Discomfort—Paclitaxel—kidney cancer	0.000188	0.000585	CcSEcCtD
Vardenafil—Gastrointestinal pain—Vincristine—kidney cancer	0.000188	0.000585	CcSEcCtD
Vardenafil—Dizziness—Sorafenib—kidney cancer	0.000187	0.000581	CcSEcCtD
Vardenafil—Pain—Gemcitabine—kidney cancer	0.000187	0.00058	CcSEcCtD
Vardenafil—Nausea—Erlotinib—kidney cancer	0.000187	0.00058	CcSEcCtD
Vardenafil—Dry mouth—Paclitaxel—kidney cancer	0.000186	0.000579	CcSEcCtD
Vardenafil—Diarrhoea—Sunitinib—kidney cancer	0.000186	0.000578	CcSEcCtD
Vardenafil—Mental disorder—Capecitabine—kidney cancer	0.000185	0.000575	CcSEcCtD
Vardenafil—Asthenia—Dactinomycin—kidney cancer	0.000185	0.000574	CcSEcCtD
Vardenafil—Blood creatinine increased—Doxorubicin—kidney cancer	0.000184	0.000573	CcSEcCtD
Vardenafil—Erythema—Capecitabine—kidney cancer	0.000184	0.000571	CcSEcCtD
Vardenafil—Anaphylactic shock—Paclitaxel—kidney cancer	0.000183	0.000568	CcSEcCtD
Vardenafil—Abdominal pain—Vincristine—kidney cancer	0.000182	0.000565	CcSEcCtD
Vardenafil—Liver function test abnormal—Doxorubicin—kidney cancer	0.000181	0.000564	CcSEcCtD
Vardenafil—Infection—Paclitaxel—kidney cancer	0.000181	0.000564	CcSEcCtD
Vardenafil—Dizziness—Sunitinib—kidney cancer	0.00018	0.000559	CcSEcCtD
Vardenafil—Feeling abnormal—Gemcitabine—kidney cancer	0.00018	0.000559	CcSEcCtD
Vardenafil—Shock—Paclitaxel—kidney cancer	0.00018	0.000559	CcSEcCtD
Vardenafil—Vomiting—Sorafenib—kidney cancer	0.00018	0.000559	CcSEcCtD
Vardenafil—Orthostatic hypotension—Doxorubicin—kidney cancer	0.00018	0.000558	CcSEcCtD
Vardenafil—Abdominal pain upper—Doxorubicin—kidney cancer	0.00018	0.000558	CcSEcCtD
Vardenafil—Nervous system disorder—Paclitaxel—kidney cancer	0.000179	0.000557	CcSEcCtD
Vardenafil—Tachycardia—Paclitaxel—kidney cancer	0.000178	0.000554	CcSEcCtD
Vardenafil—Rash—Sorafenib—kidney cancer	0.000178	0.000554	CcSEcCtD
Vardenafil—Dermatitis—Sorafenib—kidney cancer	0.000178	0.000553	CcSEcCtD
Vardenafil—Back pain—Capecitabine—kidney cancer	0.000178	0.000552	CcSEcCtD
Vardenafil—Breast disorder—Doxorubicin—kidney cancer	0.000178	0.000552	CcSEcCtD
Vardenafil—Skin disorder—Paclitaxel—kidney cancer	0.000177	0.000552	CcSEcCtD
Vardenafil—Aspartate aminotransferase increased—Doxorubicin—kidney cancer	0.000177	0.00055	CcSEcCtD
Vardenafil—Headache—Sorafenib—kidney cancer	0.000177	0.00055	CcSEcCtD
Vardenafil—Muscle spasms—Capecitabine—kidney cancer	0.000177	0.000549	CcSEcCtD
Vardenafil—Hyperhidrosis—Paclitaxel—kidney cancer	0.000177	0.000549	CcSEcCtD
Vardenafil—Diarrhoea—Dactinomycin—kidney cancer	0.000176	0.000548	CcSEcCtD
Vardenafil—Gastritis—Doxorubicin—kidney cancer	0.000174	0.000541	CcSEcCtD
Vardenafil—Alanine aminotransferase increased—Doxorubicin—kidney cancer	0.000173	0.000539	CcSEcCtD
Vardenafil—Vision blurred—Capecitabine—kidney cancer	0.000173	0.000538	CcSEcCtD
Vardenafil—Vomiting—Sunitinib—kidney cancer	0.000173	0.000538	CcSEcCtD
Vardenafil—Rash—Sunitinib—kidney cancer	0.000171	0.000533	CcSEcCtD
Vardenafil—Dermatitis—Sunitinib—kidney cancer	0.000171	0.000533	CcSEcCtD
Vardenafil—Hypotension—Paclitaxel—kidney cancer	0.000171	0.000531	CcSEcCtD
Vardenafil—Ill-defined disorder—Capecitabine—kidney cancer	0.00017	0.00053	CcSEcCtD
Vardenafil—Headache—Sunitinib—kidney cancer	0.00017	0.00053	CcSEcCtD
Vardenafil—Influenza—Doxorubicin—kidney cancer	0.00017	0.000528	CcSEcCtD
Vardenafil—Dysphagia—Doxorubicin—kidney cancer	0.00017	0.000528	CcSEcCtD
Vardenafil—Hypersensitivity—Vincristine—kidney cancer	0.000169	0.000527	CcSEcCtD
Vardenafil—Nausea—Sorafenib—kidney cancer	0.000168	0.000522	CcSEcCtD
Vardenafil—Musculoskeletal discomfort—Paclitaxel—kidney cancer	0.000166	0.000517	CcSEcCtD
Vardenafil—Malaise—Capecitabine—kidney cancer	0.000166	0.000515	CcSEcCtD
Vardenafil—Angina pectoris—Doxorubicin—kidney cancer	0.000166	0.000515	CcSEcCtD
Vardenafil—Insomnia—Paclitaxel—kidney cancer	0.000165	0.000514	CcSEcCtD
Vardenafil—Vertigo—Capecitabine—kidney cancer	0.000165	0.000513	CcSEcCtD
Vardenafil—Asthenia—Vincristine—kidney cancer	0.000165	0.000513	CcSEcCtD
Vardenafil—Syncope—Capecitabine—kidney cancer	0.000165	0.000512	CcSEcCtD
Vardenafil—Paraesthesia—Paclitaxel—kidney cancer	0.000164	0.00051	CcSEcCtD
Vardenafil—Vomiting—Dactinomycin—kidney cancer	0.000164	0.000509	CcSEcCtD
Vardenafil—Dyspnoea—Paclitaxel—kidney cancer	0.000163	0.000506	CcSEcCtD
Vardenafil—Somnolence—Paclitaxel—kidney cancer	0.000162	0.000505	CcSEcCtD
Vardenafil—Palpitations—Capecitabine—kidney cancer	0.000162	0.000505	CcSEcCtD
Vardenafil—Rash—Dactinomycin—kidney cancer	0.000162	0.000505	CcSEcCtD
Vardenafil—Nausea—Sunitinib—kidney cancer	0.000161	0.000502	CcSEcCtD
Vardenafil—Loss of consciousness—Capecitabine—kidney cancer	0.000161	0.000502	CcSEcCtD
Vardenafil—Dyspepsia—Paclitaxel—kidney cancer	0.000161	0.0005	CcSEcCtD
Vardenafil—Gastrointestinal disorder—Paclitaxel—kidney cancer	0.000158	0.00049	CcSEcCtD
Vardenafil—Diarrhoea—Vincristine—kidney cancer	0.000157	0.000489	CcSEcCtD
Vardenafil—Asthenia—Gemcitabine—kidney cancer	0.000157	0.000487	CcSEcCtD
Vardenafil—Myalgia—Capecitabine—kidney cancer	0.000156	0.000486	CcSEcCtD
Vardenafil—Arthralgia—Capecitabine—kidney cancer	0.000156	0.000486	CcSEcCtD
Vardenafil—Chest pain—Capecitabine—kidney cancer	0.000156	0.000486	CcSEcCtD
Vardenafil—Pain—Paclitaxel—kidney cancer	0.000156	0.000486	CcSEcCtD
Vardenafil—Anxiety—Capecitabine—kidney cancer	0.000156	0.000485	CcSEcCtD
Vardenafil—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—kidney cancer	0.000155	0.000483	CcSEcCtD
Vardenafil—Photosensitivity reaction—Doxorubicin—kidney cancer	0.000155	0.000482	CcSEcCtD
Vardenafil—Discomfort—Capecitabine—kidney cancer	0.000154	0.00048	CcSEcCtD
Vardenafil—Pruritus—Gemcitabine—kidney cancer	0.000154	0.00048	CcSEcCtD
Vardenafil—Dry mouth—Capecitabine—kidney cancer	0.000153	0.000476	CcSEcCtD
Vardenafil—Nausea—Dactinomycin—kidney cancer	0.000153	0.000475	CcSEcCtD
Vardenafil—Dizziness—Vincristine—kidney cancer	0.000152	0.000473	CcSEcCtD
Vardenafil—Infestation—Doxorubicin—kidney cancer	0.000151	0.000471	CcSEcCtD
Vardenafil—Infestation NOS—Doxorubicin—kidney cancer	0.000151	0.000471	CcSEcCtD
Vardenafil—Feeling abnormal—Paclitaxel—kidney cancer	0.000151	0.000468	CcSEcCtD
Vardenafil—Gastrointestinal pain—Paclitaxel—kidney cancer	0.000149	0.000464	CcSEcCtD
Vardenafil—Diarrhoea—Gemcitabine—kidney cancer	0.000149	0.000464	CcSEcCtD
Vardenafil—Infection—Capecitabine—kidney cancer	0.000149	0.000463	CcSEcCtD
Vardenafil—Shock—Capecitabine—kidney cancer	0.000147	0.000459	CcSEcCtD
Vardenafil—Conjunctivitis—Doxorubicin—kidney cancer	0.000147	0.000458	CcSEcCtD
Vardenafil—Nervous system disorder—Capecitabine—kidney cancer	0.000147	0.000457	CcSEcCtD
Vardenafil—Tachycardia—Capecitabine—kidney cancer	0.000146	0.000455	CcSEcCtD
Vardenafil—Vomiting—Vincristine—kidney cancer	0.000146	0.000455	CcSEcCtD
Vardenafil—Skin disorder—Capecitabine—kidney cancer	0.000146	0.000453	CcSEcCtD
Vardenafil—Sweating—Doxorubicin—kidney cancer	0.000145	0.000452	CcSEcCtD
Vardenafil—Rash—Vincristine—kidney cancer	0.000145	0.000451	CcSEcCtD
Vardenafil—Hyperhidrosis—Capecitabine—kidney cancer	0.000145	0.000451	CcSEcCtD
Vardenafil—Dermatitis—Vincristine—kidney cancer	0.000145	0.00045	CcSEcCtD
Vardenafil—Haematuria—Doxorubicin—kidney cancer	0.000144	0.000449	CcSEcCtD
Vardenafil—Abdominal pain—Paclitaxel—kidney cancer	0.000144	0.000449	CcSEcCtD
Vardenafil—Headache—Vincristine—kidney cancer	0.000144	0.000448	CcSEcCtD
Vardenafil—Hepatobiliary disease—Doxorubicin—kidney cancer	0.000143	0.000446	CcSEcCtD
Vardenafil—Epistaxis—Doxorubicin—kidney cancer	0.000143	0.000444	CcSEcCtD
Vardenafil—Sinusitis—Doxorubicin—kidney cancer	0.000142	0.000442	CcSEcCtD
Vardenafil—Hypotension—Capecitabine—kidney cancer	0.00014	0.000436	CcSEcCtD
Vardenafil—Vomiting—Gemcitabine—kidney cancer	0.000139	0.000431	CcSEcCtD
Vardenafil—Rash—Gemcitabine—kidney cancer	0.000138	0.000428	CcSEcCtD
Vardenafil—Dermatitis—Gemcitabine—kidney cancer	0.000137	0.000427	CcSEcCtD
Vardenafil—Haemoglobin—Doxorubicin—kidney cancer	0.000137	0.000425	CcSEcCtD
Vardenafil—Headache—Gemcitabine—kidney cancer	0.000137	0.000425	CcSEcCtD
Vardenafil—Nausea—Vincristine—kidney cancer	0.000137	0.000425	CcSEcCtD
Vardenafil—Musculoskeletal discomfort—Capecitabine—kidney cancer	0.000137	0.000425	CcSEcCtD
Vardenafil—Rhinitis—Doxorubicin—kidney cancer	0.000136	0.000424	CcSEcCtD
Vardenafil—Haemorrhage—Doxorubicin—kidney cancer	0.000136	0.000423	CcSEcCtD
Vardenafil—Insomnia—Capecitabine—kidney cancer	0.000136	0.000422	CcSEcCtD
Vardenafil—Hypoaesthesia—Doxorubicin—kidney cancer	0.000135	0.000421	CcSEcCtD
Vardenafil—Pharyngitis—Doxorubicin—kidney cancer	0.000135	0.00042	CcSEcCtD
Vardenafil—Paraesthesia—Capecitabine—kidney cancer	0.000135	0.000419	CcSEcCtD
Vardenafil—Hypersensitivity—Paclitaxel—kidney cancer	0.000135	0.000418	CcSEcCtD
Vardenafil—Urinary tract disorder—Doxorubicin—kidney cancer	0.000134	0.000418	CcSEcCtD
Vardenafil—Connective tissue disorder—Doxorubicin—kidney cancer	0.000134	0.000416	CcSEcCtD
Vardenafil—Dyspnoea—Capecitabine—kidney cancer	0.000134	0.000416	CcSEcCtD
Vardenafil—Urethral disorder—Doxorubicin—kidney cancer	0.000133	0.000415	CcSEcCtD
Vardenafil—Dyspepsia—Capecitabine—kidney cancer	0.000132	0.00041	CcSEcCtD
Vardenafil—Visual impairment—Doxorubicin—kidney cancer	0.000131	0.000408	CcSEcCtD
Vardenafil—Asthenia—Paclitaxel—kidney cancer	0.000131	0.000408	CcSEcCtD
Vardenafil—Nausea—Gemcitabine—kidney cancer	0.00013	0.000403	CcSEcCtD
Vardenafil—Gastrointestinal disorder—Capecitabine—kidney cancer	0.000129	0.000402	CcSEcCtD
Vardenafil—Pruritus—Paclitaxel—kidney cancer	0.000129	0.000402	CcSEcCtD
Vardenafil—Pain—Capecitabine—kidney cancer	0.000128	0.000399	CcSEcCtD
Vardenafil—Eye disorder—Doxorubicin—kidney cancer	0.000127	0.000395	CcSEcCtD
Vardenafil—Tinnitus—Doxorubicin—kidney cancer	0.000127	0.000394	CcSEcCtD
Vardenafil—Cardiac disorder—Doxorubicin—kidney cancer	0.000126	0.000392	CcSEcCtD
Vardenafil—Flushing—Doxorubicin—kidney cancer	0.000126	0.000392	CcSEcCtD
Vardenafil—Diarrhoea—Paclitaxel—kidney cancer	0.000125	0.000389	CcSEcCtD
Vardenafil—Feeling abnormal—Capecitabine—kidney cancer	0.000124	0.000384	CcSEcCtD
Vardenafil—Angiopathy—Doxorubicin—kidney cancer	0.000123	0.000384	CcSEcCtD
Vardenafil—Immune system disorder—Doxorubicin—kidney cancer	0.000123	0.000382	CcSEcCtD
Vardenafil—Gastrointestinal pain—Capecitabine—kidney cancer	0.000123	0.000381	CcSEcCtD
Vardenafil—Mediastinal disorder—Doxorubicin—kidney cancer	0.000123	0.000381	CcSEcCtD
Vardenafil—Dizziness—Paclitaxel—kidney cancer	0.000121	0.000376	CcSEcCtD
Vardenafil—Mental disorder—Doxorubicin—kidney cancer	0.000119	0.000371	CcSEcCtD
Vardenafil—Abdominal pain—Capecitabine—kidney cancer	0.000118	0.000368	CcSEcCtD
Vardenafil—Erythema—Doxorubicin—kidney cancer	0.000118	0.000368	CcSEcCtD
Vardenafil—Vomiting—Paclitaxel—kidney cancer	0.000116	0.000361	CcSEcCtD
Vardenafil—Rash—Paclitaxel—kidney cancer	0.000115	0.000358	CcSEcCtD
Vardenafil—Dermatitis—Paclitaxel—kidney cancer	0.000115	0.000358	CcSEcCtD
Vardenafil—Back pain—Doxorubicin—kidney cancer	0.000115	0.000356	CcSEcCtD
Vardenafil—Headache—Paclitaxel—kidney cancer	0.000114	0.000356	CcSEcCtD
Vardenafil—Muscle spasms—Doxorubicin—kidney cancer	0.000114	0.000354	CcSEcCtD
Vardenafil—Vision blurred—Doxorubicin—kidney cancer	0.000112	0.000347	CcSEcCtD
Vardenafil—Hypersensitivity—Capecitabine—kidney cancer	0.00011	0.000343	CcSEcCtD
Vardenafil—Ill-defined disorder—Doxorubicin—kidney cancer	0.00011	0.000342	CcSEcCtD
Vardenafil—Nausea—Paclitaxel—kidney cancer	0.000108	0.000337	CcSEcCtD
Vardenafil—Asthenia—Capecitabine—kidney cancer	0.000108	0.000334	CcSEcCtD
Vardenafil—Malaise—Doxorubicin—kidney cancer	0.000107	0.000332	CcSEcCtD
Vardenafil—Vertigo—Doxorubicin—kidney cancer	0.000106	0.000331	CcSEcCtD
Vardenafil—Syncope—Doxorubicin—kidney cancer	0.000106	0.00033	CcSEcCtD
Vardenafil—Pruritus—Capecitabine—kidney cancer	0.000106	0.00033	CcSEcCtD
Vardenafil—Palpitations—Doxorubicin—kidney cancer	0.000105	0.000325	CcSEcCtD
Vardenafil—Loss of consciousness—Doxorubicin—kidney cancer	0.000104	0.000324	CcSEcCtD
Vardenafil—Convulsion—Doxorubicin—kidney cancer	0.000103	0.000319	CcSEcCtD
Vardenafil—Diarrhoea—Capecitabine—kidney cancer	0.000103	0.000319	CcSEcCtD
Vardenafil—Chest pain—Doxorubicin—kidney cancer	0.000101	0.000313	CcSEcCtD
Vardenafil—Arthralgia—Doxorubicin—kidney cancer	0.000101	0.000313	CcSEcCtD
Vardenafil—Myalgia—Doxorubicin—kidney cancer	0.000101	0.000313	CcSEcCtD
Vardenafil—Anxiety—Doxorubicin—kidney cancer	0.0001	0.000312	CcSEcCtD
Vardenafil—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—kidney cancer	0.0001	0.000311	CcSEcCtD
Vardenafil—Discomfort—Doxorubicin—kidney cancer	9.96e-05	0.00031	CcSEcCtD
Vardenafil—Dizziness—Capecitabine—kidney cancer	9.91e-05	0.000308	CcSEcCtD
Vardenafil—Dry mouth—Doxorubicin—kidney cancer	9.86e-05	0.000307	CcSEcCtD
Vardenafil—Anaphylactic shock—Doxorubicin—kidney cancer	9.66e-05	0.0003	CcSEcCtD
Vardenafil—Infection—Doxorubicin—kidney cancer	9.6e-05	0.000298	CcSEcCtD
Vardenafil—Vomiting—Capecitabine—kidney cancer	9.53e-05	0.000296	CcSEcCtD
Vardenafil—Shock—Doxorubicin—kidney cancer	9.51e-05	0.000296	CcSEcCtD
Vardenafil—Nervous system disorder—Doxorubicin—kidney cancer	9.48e-05	0.000295	CcSEcCtD
Vardenafil—Rash—Capecitabine—kidney cancer	9.45e-05	0.000294	CcSEcCtD
Vardenafil—Dermatitis—Capecitabine—kidney cancer	9.44e-05	0.000294	CcSEcCtD
Vardenafil—Tachycardia—Doxorubicin—kidney cancer	9.43e-05	0.000293	CcSEcCtD
Vardenafil—Headache—Capecitabine—kidney cancer	9.39e-05	0.000292	CcSEcCtD
Vardenafil—Skin disorder—Doxorubicin—kidney cancer	9.38e-05	0.000292	CcSEcCtD
Vardenafil—Hyperhidrosis—Doxorubicin—kidney cancer	9.34e-05	0.00029	CcSEcCtD
Vardenafil—Hypotension—Doxorubicin—kidney cancer	9.03e-05	0.000281	CcSEcCtD
Vardenafil—Nausea—Capecitabine—kidney cancer	8.9e-05	0.000277	CcSEcCtD
Vardenafil—Musculoskeletal discomfort—Doxorubicin—kidney cancer	8.8e-05	0.000274	CcSEcCtD
Vardenafil—Insomnia—Doxorubicin—kidney cancer	8.74e-05	0.000272	CcSEcCtD
Vardenafil—Paraesthesia—Doxorubicin—kidney cancer	8.68e-05	0.00027	CcSEcCtD
Vardenafil—Dyspnoea—Doxorubicin—kidney cancer	8.61e-05	0.000268	CcSEcCtD
Vardenafil—Somnolence—Doxorubicin—kidney cancer	8.59e-05	0.000267	CcSEcCtD
Vardenafil—Dyspepsia—Doxorubicin—kidney cancer	8.5e-05	0.000264	CcSEcCtD
Vardenafil—Gastrointestinal disorder—Doxorubicin—kidney cancer	8.34e-05	0.000259	CcSEcCtD
Vardenafil—Pain—Doxorubicin—kidney cancer	8.26e-05	0.000257	CcSEcCtD
Vardenafil—Feeling abnormal—Doxorubicin—kidney cancer	7.96e-05	0.000248	CcSEcCtD
Vardenafil—Gastrointestinal pain—Doxorubicin—kidney cancer	7.9e-05	0.000246	CcSEcCtD
Vardenafil—Abdominal pain—Doxorubicin—kidney cancer	7.64e-05	0.000238	CcSEcCtD
Vardenafil—Hypersensitivity—Doxorubicin—kidney cancer	7.12e-05	0.000221	CcSEcCtD
Vardenafil—Asthenia—Doxorubicin—kidney cancer	6.93e-05	0.000216	CcSEcCtD
Vardenafil—Pruritus—Doxorubicin—kidney cancer	6.84e-05	0.000213	CcSEcCtD
Vardenafil—Diarrhoea—Doxorubicin—kidney cancer	6.61e-05	0.000206	CcSEcCtD
Vardenafil—Dizziness—Doxorubicin—kidney cancer	6.39e-05	0.000199	CcSEcCtD
Vardenafil—Vomiting—Doxorubicin—kidney cancer	6.14e-05	0.000191	CcSEcCtD
Vardenafil—Rash—Doxorubicin—kidney cancer	6.09e-05	0.000189	CcSEcCtD
Vardenafil—Dermatitis—Doxorubicin—kidney cancer	6.09e-05	0.000189	CcSEcCtD
Vardenafil—Headache—Doxorubicin—kidney cancer	6.05e-05	0.000188	CcSEcCtD
Vardenafil—Nausea—Doxorubicin—kidney cancer	5.74e-05	0.000178	CcSEcCtD
Vardenafil—PDE1B—Signaling Pathways—CTNNA1—kidney cancer	4.7e-05	0.000321	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—HSPB1—kidney cancer	4.68e-05	0.000319	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—EIF4EBP1—kidney cancer	4.68e-05	0.000319	CbGpPWpGaD
Vardenafil—PDE1B—Innate Immune System—RAF1—kidney cancer	4.66e-05	0.000318	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—BRAF—kidney cancer	4.66e-05	0.000318	CbGpPWpGaD
Vardenafil—PDE6G—Disease—CDKN1B—kidney cancer	4.65e-05	0.000318	CbGpPWpGaD
Vardenafil—PDE1B—Hemostasis—IL2—kidney cancer	4.64e-05	0.000317	CbGpPWpGaD
Vardenafil—PDE1B—Innate Immune System—RELA—kidney cancer	4.64e-05	0.000317	CbGpPWpGaD
Vardenafil—PDE1B—Innate Immune System—ERBB2—kidney cancer	4.61e-05	0.000315	CbGpPWpGaD
Vardenafil—PDE1B—Immune System—CD8A—kidney cancer	4.61e-05	0.000315	CbGpPWpGaD
Vardenafil—PDE1B—Innate Immune System—MTOR—kidney cancer	4.55e-05	0.000311	CbGpPWpGaD
Vardenafil—PDE1B—Innate Immune System—CD4—kidney cancer	4.54e-05	0.00031	CbGpPWpGaD
Vardenafil—PDE1B—Disease—CDKN2B—kidney cancer	4.54e-05	0.00031	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—APC—kidney cancer	4.53e-05	0.000309	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—KIT—kidney cancer	4.53e-05	0.000309	CbGpPWpGaD
Vardenafil—PDE11A—Signaling by GPCR—MAPK1—kidney cancer	4.51e-05	0.000308	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—FH—kidney cancer	4.51e-05	0.000308	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—APRT—kidney cancer	4.51e-05	0.000308	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—KIT—kidney cancer	4.41e-05	0.000301	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—APC—kidney cancer	4.41e-05	0.000301	CbGpPWpGaD
Vardenafil—PDE6G—Disease—CTNNB1—kidney cancer	4.39e-05	0.0003	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—ANXA1—kidney cancer	4.35e-05	0.000297	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—PSMD7—kidney cancer	4.35e-05	0.000297	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—TSC1—kidney cancer	4.35e-05	0.000297	CbGpPWpGaD
Vardenafil—PDE11A—GPCR downstream signaling—PIK3CA—kidney cancer	4.31e-05	0.000294	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—POMC—kidney cancer	4.31e-05	0.000294	CbGpPWpGaD
Vardenafil—PDE6G—Disease—PTEN—kidney cancer	4.28e-05	0.000292	CbGpPWpGaD
Vardenafil—PDE1B—Innate Immune System—CDKN1B—kidney cancer	4.27e-05	0.000292	CbGpPWpGaD
Vardenafil—PDE11A—Signaling by GPCR—KRAS—kidney cancer	4.26e-05	0.000291	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—BRAF—kidney cancer	4.26e-05	0.000291	CbGpPWpGaD
Vardenafil—CYP3A4—Biological oxidations—GSTP1—kidney cancer	4.24e-05	0.00029	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—GPC3—kidney cancer	4.24e-05	0.000289	CbGpPWpGaD
Vardenafil—PDE10A—Signaling by GPCR—MAPK3—kidney cancer	4.23e-05	0.000289	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—FLT1—kidney cancer	4.21e-05	0.000287	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—POMC—kidney cancer	4.2e-05	0.000287	CbGpPWpGaD
Vardenafil—CYP3A4—Metapathway biotransformation—GSTP1—kidney cancer	4.19e-05	0.000286	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—BRAF—kidney cancer	4.15e-05	0.000283	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—CA2—kidney cancer	4.12e-05	0.000282	CbGpPWpGaD
Vardenafil—PDE1B—Innate Immune System—JUN—kidney cancer	4.07e-05	0.000278	CbGpPWpGaD
Vardenafil—PDE1B—Innate Immune System—CTNNB1—kidney cancer	4.04e-05	0.000276	CbGpPWpGaD
Vardenafil—PDE10A—Signaling by GPCR—MAPK1—kidney cancer	4.02e-05	0.000275	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—ALAD—kidney cancer	4.02e-05	0.000274	CbGpPWpGaD
Vardenafil—PDE1B—GPCR downstream signaling—POMC—kidney cancer	3.97e-05	0.000271	CbGpPWpGaD
Vardenafil—PDE1B—Hemostasis—VEGFA—kidney cancer	3.95e-05	0.000269	CbGpPWpGaD
Vardenafil—PDE1B—Innate Immune System—PTEN—kidney cancer	3.93e-05	0.000269	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—ST3GAL2—kidney cancer	3.92e-05	0.000268	CbGpPWpGaD
Vardenafil—PDE1B—Immune System—TSC2—kidney cancer	3.92e-05	0.000268	CbGpPWpGaD
Vardenafil—PDE11A—Signaling by GPCR—PIK3CA—kidney cancer	3.92e-05	0.000267	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—PAK1—kidney cancer	3.9e-05	0.000266	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—JUNB—kidney cancer	3.9e-05	0.000266	CbGpPWpGaD
Vardenafil—CYP3A4—Biological oxidations—GSTM1—kidney cancer	3.9e-05	0.000266	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—RAF1—kidney cancer	3.89e-05	0.000265	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—RELA—kidney cancer	3.87e-05	0.000264	CbGpPWpGaD
Vardenafil—CYP3A4—Metapathway biotransformation—GSTM1—kidney cancer	3.85e-05	0.000263	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—ERBB2—kidney cancer	3.85e-05	0.000263	CbGpPWpGaD
Vardenafil—PDE10A—GPCR downstream signaling—PIK3CA—kidney cancer	3.84e-05	0.000262	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—ALDH1A1—kidney cancer	3.83e-05	0.000262	CbGpPWpGaD
Vardenafil—PDE10A—Signaling by GPCR—KRAS—kidney cancer	3.8e-05	0.000259	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—MTOR—kidney cancer	3.79e-05	0.000259	CbGpPWpGaD
Vardenafil—PDE1B—Hemostasis—MAPK3—kidney cancer	3.73e-05	0.000255	CbGpPWpGaD
Vardenafil—CYP3A4—Biological oxidations—CYP1A1—kidney cancer	3.7e-05	0.000252	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—PGK1—kidney cancer	3.67e-05	0.000251	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—SLC5A3—kidney cancer	3.67e-05	0.000251	CbGpPWpGaD
Vardenafil—PDE6G—Disease—MAPK3—kidney cancer	3.66e-05	0.00025	CbGpPWpGaD
Vardenafil—CYP3A4—Metapathway biotransformation—CYP1A1—kidney cancer	3.65e-05	0.000249	CbGpPWpGaD
Vardenafil—PDE1B—Disease—HIF1A—kidney cancer	3.63e-05	0.000248	CbGpPWpGaD
Vardenafil—PDE1B—Disease—TSC2—kidney cancer	3.62e-05	0.000247	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by GPCR—POMC—kidney cancer	3.6e-05	0.000246	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—LDHB—kidney cancer	3.6e-05	0.000246	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—CDKN1B—kidney cancer	3.56e-05	0.000243	CbGpPWpGaD
Vardenafil—PDE6G—Disease—MYC—kidney cancer	3.56e-05	0.000243	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—RAF1—kidney cancer	3.55e-05	0.000243	CbGpPWpGaD
Vardenafil—PDE1B—Hemostasis—MAPK1—kidney cancer	3.55e-05	0.000243	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—RELA—kidney cancer	3.54e-05	0.000242	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—ERBB2—kidney cancer	3.52e-05	0.00024	CbGpPWpGaD
Vardenafil—PDE10A—Signaling by GPCR—PIK3CA—kidney cancer	3.49e-05	0.000238	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—IL2—kidney cancer	3.49e-05	0.000238	CbGpPWpGaD
Vardenafil—PDE6G—Disease—MAPK1—kidney cancer	3.48e-05	0.000238	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—MTOR—kidney cancer	3.47e-05	0.000237	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—RAF1—kidney cancer	3.46e-05	0.000237	CbGpPWpGaD
Vardenafil—PDE1B—Immune System—KIT—kidney cancer	3.46e-05	0.000236	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—RELA—kidney cancer	3.45e-05	0.000236	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—ERBB2—kidney cancer	3.43e-05	0.000234	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—CCND1—kidney cancer	3.4e-05	0.000232	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—JUN—kidney cancer	3.39e-05	0.000232	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—MTOR—kidney cancer	3.38e-05	0.000231	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—CTNNB1—kidney cancer	3.36e-05	0.00023	CbGpPWpGaD
Vardenafil—PDE1B—Innate Immune System—MAPK3—kidney cancer	3.36e-05	0.00023	CbGpPWpGaD
Vardenafil—PDE1B—Hemostasis—KRAS—kidney cancer	3.35e-05	0.000229	CbGpPWpGaD
Vardenafil—PDE6G—Disease—KRAS—kidney cancer	3.29e-05	0.000225	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—PTEN—kidney cancer	3.28e-05	0.000224	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—CDKN1B—kidney cancer	3.26e-05	0.000222	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—ACY1—kidney cancer	3.25e-05	0.000222	CbGpPWpGaD
Vardenafil—PDE1B—Innate Immune System—MAPK1—kidney cancer	3.2e-05	0.000218	CbGpPWpGaD
Vardenafil—PDE1B—Disease—KIT—kidney cancer	3.19e-05	0.000218	CbGpPWpGaD
Vardenafil—PDE1B—Disease—APC—kidney cancer	3.19e-05	0.000218	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—IGF2—kidney cancer	3.19e-05	0.000218	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—IL2—kidney cancer	3.19e-05	0.000218	CbGpPWpGaD
Vardenafil—PDE1B—Immune System—CDH1—kidney cancer	3.18e-05	0.000217	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—CDKN2B—kidney cancer	3.18e-05	0.000217	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—CDKN1B—kidney cancer	3.17e-05	0.000217	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—CA9—kidney cancer	3.12e-05	0.000213	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—CCND1—kidney cancer	3.11e-05	0.000212	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—IL2—kidney cancer	3.11e-05	0.000212	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—JUN—kidney cancer	3.1e-05	0.000212	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—IGF1R—kidney cancer	3.08e-05	0.000211	CbGpPWpGaD
Vardenafil—PDE1B—Hemostasis—PIK3CA—kidney cancer	3.08e-05	0.00021	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—CTNNB1—kidney cancer	3.08e-05	0.00021	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—CCND1—kidney cancer	3.03e-05	0.000207	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—JUN—kidney cancer	3.02e-05	0.000206	CbGpPWpGaD
Vardenafil—PDE6G—Disease—PIK3CA—kidney cancer	3.02e-05	0.000206	CbGpPWpGaD
Vardenafil—PDE1B—Innate Immune System—KRAS—kidney cancer	3.02e-05	0.000206	CbGpPWpGaD
Vardenafil—PDE1B—Disease—BRAF—kidney cancer	3e-05	0.000205	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—PTEN—kidney cancer	3e-05	0.000205	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—CTNNB1—kidney cancer	3e-05	0.000205	CbGpPWpGaD
Vardenafil—PDE1B—Hemostasis—TP53—kidney cancer	2.98e-05	0.000204	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by GPCR—RAF1—kidney cancer	2.97e-05	0.000203	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—VEGFA—kidney cancer	2.96e-05	0.000202	CbGpPWpGaD
Vardenafil—PDE1B—GPCR downstream signaling—IL2—kidney cancer	2.93e-05	0.0002	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—PTEN—kidney cancer	2.92e-05	0.0002	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—MAPK3—kidney cancer	2.8e-05	0.000191	CbGpPWpGaD
Vardenafil—PDE1B—Innate Immune System—PIK3CA—kidney cancer	2.77e-05	0.000189	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—PDHB—kidney cancer	2.77e-05	0.000189	CbGpPWpGaD
Vardenafil—CYP3A4—Biological oxidations—POMC—kidney cancer	2.76e-05	0.000188	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—MYC—kidney cancer	2.73e-05	0.000186	CbGpPWpGaD
Vardenafil—PDE1B—Immune System—RAF1—kidney cancer	2.72e-05	0.000185	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—VEGFA—kidney cancer	2.71e-05	0.000185	CbGpPWpGaD
Vardenafil—PDE1B—Immune System—RELA—kidney cancer	2.7e-05	0.000185	CbGpPWpGaD
Vardenafil—PDE1B—Immune System—ERBB2—kidney cancer	2.69e-05	0.000183	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—MAPK1—kidney cancer	2.67e-05	0.000182	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by GPCR—IL2—kidney cancer	2.66e-05	0.000182	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—CRABP1—kidney cancer	2.66e-05	0.000181	CbGpPWpGaD
Vardenafil—PDE1B—Immune System—MTOR—kidney cancer	2.65e-05	0.000181	CbGpPWpGaD
Vardenafil—PDE1B—Immune System—CD4—kidney cancer	2.65e-05	0.000181	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—VEGFA—kidney cancer	2.64e-05	0.00018	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—CCBL1—kidney cancer	2.6e-05	0.000178	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—MAPK3—kidney cancer	2.56e-05	0.000175	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—HIF1A—kidney cancer	2.54e-05	0.000173	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—TSC2—kidney cancer	2.53e-05	0.000173	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—KRAS—kidney cancer	2.52e-05	0.000172	CbGpPWpGaD
Vardenafil—PDE1B—Disease—RAF1—kidney cancer	2.51e-05	0.000171	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—MAPK3—kidney cancer	2.5e-05	0.000171	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—MYC—kidney cancer	2.49e-05	0.00017	CbGpPWpGaD
Vardenafil—PDE1B—Immune System—CDKN1B—kidney cancer	2.49e-05	0.00017	CbGpPWpGaD
Vardenafil—PDE1B—Disease—ERBB2—kidney cancer	2.48e-05	0.000169	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—ITPR2—kidney cancer	2.47e-05	0.000169	CbGpPWpGaD
Vardenafil—PDE1B—Disease—MTOR—kidney cancer	2.45e-05	0.000167	CbGpPWpGaD
Vardenafil—PDE1B—Disease—CD4—kidney cancer	2.44e-05	0.000167	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—MAPK1—kidney cancer	2.44e-05	0.000167	CbGpPWpGaD
Vardenafil—PDE1B—Immune System—IL2—kidney cancer	2.43e-05	0.000166	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—MYC—kidney cancer	2.43e-05	0.000166	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—KDR—kidney cancer	2.43e-05	0.000166	CbGpPWpGaD
Vardenafil—PDE1B—Disease—PTGS2—kidney cancer	2.43e-05	0.000166	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—MAPK1—kidney cancer	2.38e-05	0.000162	CbGpPWpGaD
Vardenafil—PDE1B—Immune System—JUN—kidney cancer	2.37e-05	0.000162	CbGpPWpGaD
Vardenafil—PDE1B—Immune System—CTNNB1—kidney cancer	2.35e-05	0.000161	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—PIK3CA—kidney cancer	2.31e-05	0.000158	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—KRAS—kidney cancer	2.3e-05	0.000157	CbGpPWpGaD
Vardenafil—PDE1B—Disease—CDKN1B—kidney cancer	2.3e-05	0.000157	CbGpPWpGaD
Vardenafil—PDE1B—Immune System—PTEN—kidney cancer	2.29e-05	0.000156	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—PPAT—kidney cancer	2.25e-05	0.000154	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—GLIPR1—kidney cancer	2.25e-05	0.000154	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—GSTT1—kidney cancer	2.25e-05	0.000154	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—ACHE—kidney cancer	2.25e-05	0.000154	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—KRAS—kidney cancer	2.24e-05	0.000153	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—TP53—kidney cancer	2.24e-05	0.000153	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—APC—kidney cancer	2.24e-05	0.000153	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—KIT—kidney cancer	2.24e-05	0.000153	CbGpPWpGaD
Vardenafil—PDE1B—Disease—CTNNB1—kidney cancer	2.17e-05	0.000148	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by GPCR—MAPK3—kidney cancer	2.14e-05	0.000146	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—SCARB1—kidney cancer	2.13e-05	0.000146	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—POMC—kidney cancer	2.13e-05	0.000145	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—PIK3CA—kidney cancer	2.12e-05	0.000144	CbGpPWpGaD
Vardenafil—PDE1B—Disease—PTEN—kidney cancer	2.12e-05	0.000144	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—PTGS1—kidney cancer	2.11e-05	0.000144	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—BRAF—kidney cancer	2.1e-05	0.000144	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—FH—kidney cancer	2.1e-05	0.000143	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—APRT—kidney cancer	2.1e-05	0.000143	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—PSMD7—kidney cancer	2.07e-05	0.000141	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—PIK3CA—kidney cancer	2.06e-05	0.000141	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—TP53—kidney cancer	2.05e-05	0.00014	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by GPCR—MAPK1—kidney cancer	2.04e-05	0.000139	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—TP53—kidney cancer	1.99e-05	0.000136	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—GPC3—kidney cancer	1.97e-05	0.000135	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—BCHE—kidney cancer	1.96e-05	0.000134	CbGpPWpGaD
Vardenafil—PDE1B—Immune System—MAPK3—kidney cancer	1.96e-05	0.000134	CbGpPWpGaD
Vardenafil—PDE1B—GPCR downstream signaling—PIK3CA—kidney cancer	1.95e-05	0.000133	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—SLC5A5—kidney cancer	1.94e-05	0.000132	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by GPCR—KRAS—kidney cancer	1.93e-05	0.000131	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—CA2—kidney cancer	1.92e-05	0.000131	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—SLC2A1—kidney cancer	1.87e-05	0.000128	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—ALAD—kidney cancer	1.87e-05	0.000128	CbGpPWpGaD
Vardenafil—PDE1B—Immune System—MAPK1—kidney cancer	1.86e-05	0.000127	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—ST3GAL2—kidney cancer	1.82e-05	0.000125	CbGpPWpGaD
Vardenafil—PDE1B—Disease—MAPK3—kidney cancer	1.81e-05	0.000123	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—ALDH1A1—kidney cancer	1.78e-05	0.000122	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by GPCR—PIK3CA—kidney cancer	1.77e-05	0.000121	CbGpPWpGaD
Vardenafil—PDE1B—Immune System—KRAS—kidney cancer	1.76e-05	0.00012	CbGpPWpGaD
Vardenafil—PDE1B—Disease—MYC—kidney cancer	1.76e-05	0.00012	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—RAF1—kidney cancer	1.76e-05	0.00012	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—RELA—kidney cancer	1.75e-05	0.000119	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—ERBB2—kidney cancer	1.74e-05	0.000119	CbGpPWpGaD
Vardenafil—PDE1B—Disease—MAPK1—kidney cancer	1.72e-05	0.000117	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—MTOR—kidney cancer	1.71e-05	0.000117	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—PGK1—kidney cancer	1.71e-05	0.000117	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—SLC5A3—kidney cancer	1.71e-05	0.000117	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—LDHB—kidney cancer	1.68e-05	0.000114	CbGpPWpGaD
Vardenafil—PDE1B—Disease—KRAS—kidney cancer	1.62e-05	0.000111	CbGpPWpGaD
Vardenafil—PDE1B—Immune System—PIK3CA—kidney cancer	1.62e-05	0.00011	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—CDKN1B—kidney cancer	1.61e-05	0.00011	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—IL2—kidney cancer	1.57e-05	0.000108	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—GSTP1—kidney cancer	1.56e-05	0.000107	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—CCND1—kidney cancer	1.53e-05	0.000105	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—JUN—kidney cancer	1.53e-05	0.000105	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—CTNNB1—kidney cancer	1.52e-05	0.000104	CbGpPWpGaD
Vardenafil—PDE1B—Disease—PIK3CA—kidney cancer	1.49e-05	0.000102	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—PTEN—kidney cancer	1.48e-05	0.000101	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—ABCB1—kidney cancer	1.48e-05	0.000101	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—CA9—kidney cancer	1.45e-05	9.92e-05	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—GSTM1—kidney cancer	1.43e-05	9.8e-05	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—CYP1A1—kidney cancer	1.36e-05	9.29e-05	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—VEGFA—kidney cancer	1.34e-05	9.14e-05	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—MAPK3—kidney cancer	1.27e-05	8.64e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—CRABP1—kidney cancer	1.24e-05	8.43e-05	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—MYC—kidney cancer	1.23e-05	8.41e-05	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—MAPK1—kidney cancer	1.2e-05	8.22e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—ITPR2—kidney cancer	1.15e-05	7.84e-05	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—KRAS—kidney cancer	1.14e-05	7.77e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—ACHE—kidney cancer	1.05e-05	7.15e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—GSTT1—kidney cancer	1.05e-05	7.15e-05	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—PIK3CA—kidney cancer	1.04e-05	7.14e-05	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—POMC—kidney cancer	1.01e-05	6.92e-05	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—TP53—kidney cancer	1.01e-05	6.9e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—SCARB1—kidney cancer	9.91e-06	6.77e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—PTGS1—kidney cancer	9.81e-06	6.7e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—PSMD7—kidney cancer	9.62e-06	6.57e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—BCHE—kidney cancer	9.12e-06	6.23e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—SLC5A5—kidney cancer	9.01e-06	6.15e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—SLC2A1—kidney cancer	8.7e-06	5.94e-05	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—PTGS2—kidney cancer	8.09e-06	5.52e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—GSTP1—kidney cancer	7.26e-06	4.96e-05	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—PTEN—kidney cancer	7.05e-06	4.82e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—ABCB1—kidney cancer	6.87e-06	4.69e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—GSTM1—kidney cancer	6.67e-06	4.55e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—CYP1A1—kidney cancer	6.32e-06	4.32e-05	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—PIK3CA—kidney cancer	4.98e-06	3.4e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—POMC—kidney cancer	4.71e-06	3.22e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—PTGS2—kidney cancer	3.76e-06	2.57e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—PTEN—kidney cancer	3.28e-06	2.24e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—PIK3CA—kidney cancer	2.31e-06	1.58e-05	CbGpPWpGaD
